Unveiling ASD Early Risk Identification Within Days of Birth
NeuroQure's ASD Insight early autism risk detection test is the first of its kind. The test uses a minimally invasive skin sample to predict the risk for autism in approximately 75% of people who will go on to develop autism.
That means simple identification of risk years earlier than traditional methods, maximizing the chance to engage with therapies and intervening as soon as possible before many developmental milestones have passed.
Transforming Autism Risk Detection for Families and Physicians
NeuroQure is bridging the gap and paving the way for improved outcomes and personalized care in autism spectrum disorders at an earlier age than ever.
By bridging the gap between markers and early intervention, NeuroQure is paving the way for improved outcomes and personalized care in autism spectrum disorders.
How the ASD Insight Early Autism Detection Test Works
Tissue sample or discarded foreskin
Tissue sent to NeuroQure's Lab
Cultured tissues analyzed using patented technique
Results delivered in weeks
Key Features of NeuroQure’s ASD Insight Test
Earliest Detection: Identify autism risk as soon as days after birth.
High Accuracy: Up to 75% likelihood in detecting autism risk.
Non-Invasive: Uses a minimally invasive skin biopsy.
Rapid Results: Get answers within days, not years.
Actionable Insights: Gain insights to tailor intervention plans.
The Science Behind NeuroQure's ASD Insight Test
Our first-of-its-kind early ASD Insight autism risk detection test uses a small skin sample to predict the risk of autism with up to 75% accuracy.
By providing the opportunity to reduce time to diagnosis, NeuroQure enables parents and healthcare providers to implement safe, tailored infant stimulation treatment plans promptly, potentially altering the course of a child's development for the better.
Frequently Asked Questions
- The early autism risk detection test is recommended for use in people with an elevated risk for Autism, such as newborns from those with a previous family history, or where there is concern infants are not meeting developmental milestones. The early Autism detection test does not detect all types of Autism and should be used in addition to routine Autism screening tests recommended by a healthcare provider. The early Autism detection test is intended to detect cellular biophysical signals highly correlated with diagnosis of ASD. Use of the early Autism detection test is not recommended in individuals who are pregnant or undergoing active Autism treatment.
- Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of “No Autism Signal Detected” does not rule out Autism; 25% of those with ADOS-diagnosed ASD signal in the neurotypical range. The test interpretation is designed to in this fashion to minimize any false-positive results. A test result of “Autism Signal Detected” requires confirmatory medical diagnostic evaluation or by medically established procedures (e.g. ADOS) to confirm Autism.
- If Autism is not clinically confirmed, it could mean that the patient is still too young to manifest symptoms or that Autism is not present or testing was insufficient to detect Autism, including due to a limited skin sample. False-positive (an autism signal detected when autism is not present) and false-negative (a autism signal not detected when autism is present) test results do occur. Rx only.
Empower Early Risk Detection, Transform Lives
Get started with NeuroQure's ASD Insight autism risk test today.